Monster Beverage Corp vs Altria Group Inc — how do they compare? Monster Beverage Corp trades at $94.53 (market cap $93.35B), while Altria Group Inc trades at $74.53 (market cap $124.67B). The key difference: Altria Group Inc is the larger of the two by market cap, and Altria Group Inc pays a 5.68% dividend while Monster Beverage Corp pays none. Which is the better fit depends on your goals.
| MNST | MO | |
|---|---|---|
Market Cap | $93.35B | $124.67B |
Sector | Consumer Staples | Consumer Staples |
52-Week High | $99.94 | $74.66 |
52-Week Low | $58.75 | $54.72 |
Enterprise Value | $91.65B | $145.75B |
Dividend Yield | — | 5.68% |
Trailing returns across standard periods
Latest headlines on both assets
Monster Beverage is a leader in the energy drink subsegment of the beverage industry. The Monster trademark anchors the portfolio, and notable offerings include Monster Energy and Monster Ultra. The firm has also started to incubate new trademarks for emerging enclaves of the energy space, like Reign in performance energy. It is primarily a brand owner, outsourcing most of its manufacturing processes to third-party copackers. It primarily uses the Coca-Cola bottling system for distribution after a strategic agreement in which Coke became Monster's largest shareholder (nearly 20%) and that also included the exchange of certain businesses between the two firms. Most of Monster's revenue is generated in the United States, though international geographies are increasing in the mix.
Read more on MNST →Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).
Read more on MO →